To investigate the effect of addition of modi®ed guar gum (GG) to a low-energy semisolid meal on appetite and body weight (BW) loss. SUBJECTS: Twenty eight mainly overweight male volunteers (age, 19 ± 56 y; body mass index, 29 AE 2 kg m
Introduction
The increasing incidence of obesity is a recognized medical problem in developed countries. 1 Obesity is known to be related to increased risks of coronary heart diseases, hypertension, non-insulin-dependent diabetes mellitus and certain types of cancer. 2 ± 4 Factors suggested to be related to the development of obesity are decreased physical activity and increased energy intake, especially fat intake. Weight loss and loss of body fat can thus be achieved by reducing energy intake andaor increasing energy expenditure. Low-energy diets have been shown to be successful in the reduction of body weight on the short term. However, during long-term treatment, decreased compliance and increased habituation to an energy-restricted diet accompanied by increased appetite 5 may result in unsuccessful weight loss or prevention of weight regain. Reduced hunger and increased satiety feelings may improve compliance to an energy-restricted diet. 6 Therefore, identi®cation of substances that improve or sustain satiety during energy restriction is needed for the treatment of obesity. The effects of dietary ®ber on appetite, energy intake andaor body weight have been extensively investigated and reported in a number of reviews. 7 ± 9 Dietary ®ber such as guar gum (GG) was found to effectively increase fullness and satiety, resulting in reduced energy intake.
10,11
It has been proposed that soluble viscous ®ber, such as (GG), may decrease the rate of gastric emptying and small intestinal transit, 12 ± 14 resulting in a delayed glucose absorption 15 and a prolonged feeling of satiety. 16 The lowered energy intake and increased satiety feeling may be bene®cial for short-term weight loss 10 and long-term weight maintenance. 17, 18 Controversial ®ndings have been shown on the effects of different types of dietary ®ber along with an energy-restricted diet on food intake andaor body weight loss. 6,19 ± 23 To our knowledge, only one study investigated the effects of GG supplementation during energy restriction on energy intake, hunger and satiety. 11 The hunger-reducing effect of GG during the energy restricted condition suggested that GG may be useful in the treatment of obesity, by increasing the compliance to a low-energy diet. Moreover, we assessed a new type of GG, namely a highly puri®ed dietary galactomannan ®ber that forms a gel in 5 ± 7 min after adding water. Furthermore we combined the energy-providing meal directly with the GG.
The aim of the present study was to test the hypothesis that the addition of modi®ed GG to a ready-to-eat low energy semisolid meal was effective in sustaining satiety while reducing food intake. It was hypothesized that GG addition to a low-energy semisolid meal would lead to gel forming in the stomach, resulting in sustained feeling of satiety or prevention of increase of appetite or hunger. Moreover, this was expected to result in a more effective body weight (BW) loss. Furthermore, since the possible effect of a treatment with the ready-to-eat low-energy semisolid meal has not been tested yet, another aim of the study was to compare the effects of the semisolid meal itself with a selfprepared low-energy solid diet on appetite and BW loss.
Methods

Subjects
The study was started with 36 male mainly overweight subjects who were recruited by advertisements in local newspapers. Eight subjects dropped out of the study: six subjects stopped participation before (baseline) or during the ®rst intervention because they were not able to follow our prescriptions, mostly because of a lack of time, and two subjects stopped during the third intervention because they moved far away. Statistical analysis revealed no difference in the number of dropouts between treatment sequences. Therefore the data presented in this study are based upon 28 subjects. Baseline subject characteristics are presented in Table 1 . The nature and risks of the experimental procedure were explained to the subjects, and all subjects gave their written informed consent. The study protocol was approved by the Ethical Committee of the Maastricht University.
Experimental design
The experimental design consisted of a baseline period of 1 week and then three intervention periods of 2 weeks in a randomized cross-over design. The intervention periods were separated by washout periods of 4 weeks ( Figure 1 ).
During baseline and the washout periods, the subjects consumed a self-selected diet. During the intervention periods, the subjects consumed for breakfast, lunch and as a four o'clock snack a low-energy meal. In addition, for lunch, subjects were allowed to eat a piece of fruit (eg apple, pear or orange). For dinner, the subjects ingested what they liked, but they were instructed to drink not more than one glass of alcoholic beverage or soft drink. Subjects were instructed to refrain from snacks between meals. During the day, the subjects were allowed to drink ad libitum water, coffee and tea (without sugar and milk).
The low-energy meal consisted of a semisolid meal (Milical Cre Áme, Laboratoires Die Âte Âtique et Sante Â, Revel, France) with (SSM ) or without (SSM) supplementation of 2.5 g of a new type of modi®ed GG (Meypro®n 1 M-175, Meyhall AG, Kreuzlingen, Switzerland), a highly puri®ed dietary galactomannan ®ber which forms a gel in about 5 ± 7 min after adding water, or a solid meal (SM) with the same energy content and macronutrient composition (energy, 947 kJ; protein, 17.9 g; carbohydrate, 21.0 g; fat, 7.9 g), which was prepared by the subjects themselves using our instructions. Acceptability of these meals was tested in the subjects as well. Subjects, matched for BMI, age, weight and blood glucose, were included in three intervention sequences, that is SSM ± SSM ± SM (n 10), SSM ± SM ± SSM (n 9), and SM ± SSM ± SSM (n 9).
Anthropometry
Body weight was measured during screening, at the beginning and at the end of baseline as well as at the beginning, after 1 week and at the end of each intervention period on a ). The distribution of fat was investigated during screening and at the end of the experiment by measuring the waist and hip circumferences and calculating the waist ± hip ratio (WHR). The waist circumference was measured at the site of the smallest circumference between the rib cage and the ileac crest, with the subjects in standing position. The hip circumference was measured at the site of the largest circumference between the waist and the thighs. The WHR was calculated by dividing the waist circumference by the hip circumference. Total body water (TBW) was measured before baseline and during each intervention period in a random subsample of 15 subjects using the deuterium ( 2 H 2 O) dilution technique. 24 The dilution of the deuterium isotope is a measure for total body water (TBW). 25 Subjects were asked to collect a urine sample in the evening just before drinking a weighed amount of deuterium-enriched water solution. After ingestion of the deuterium solution no further¯uid or food consumption was permitted. Ten hours after ingestion of the deuterium solution a second urine samples (second voiding) was collected. Deuterium concentration in the urine samples was measured using an isotope ratio mass spectrometer (Micromass Optima, Manchester, UK). TBW was obtained by dividing the measured deuterium dilution space by 1.04. 24 Fat-free mass (FFM) was calculated by dividing the TBW by the hydration factor 0.73. By subtracting FFM from BW, fat mass (FM) was obtained. FM expressed as a percentage of BW revealed body fat percentage.
Blood parameters
Systolic and diastolic blood pressure were measured during screening by an automatic blood pressure monitor (Omron 705 CP, Omron Healthcare GmbH, Hamburg, Germany). A fasted blood sample (2 ml) was obtained and mixed with EDTA to prevent clotting. Plasma was obtained by centrifugation and then stored at À20 C until analysis of glucose by a hexokinase method (Cobas Bio, Roche Diagnostics, Hoffmann-La Roche, Basel, Switzerland).
Eating behavior
Eating behavior was analyzed during screening as well as at the beginning and at the end of baseline and of each intervention period using a validated Dutch translation of the Three Factor Eating Questionnaire (TFEQ). 26, 27 Cognitive restrained and unrestrained eating behavior (factor 1), emotional eating and disinhibition (factor 2) and the subjective feeling of hunger (factor 3) were scored. Body weight¯uctua-tion was investigated with the Herman Polivy questionnaire (HP). 28 
Food intake
Food intake and meal frequency were recorded during the last 7 days of each intervention period using a food intake diary. Personal instruction was given in advance. The food intake diaries were analyzed using the Dutch food composition table 29 and the accessory computer program (Becel Nutrition Program 1988).
Compliance of the subjects to the dietary instructions was checked using the food intake diaries. For each incorrect food intake action (eg consumption of only two lowenergy meals during a day, extra alcoholic beverage during Guar gum and appetite EMR Kovacs et al dinner, sugar in coffee) they scored a noncompliance point. Compliance to dietary instructions was analyzed using these points.
Accuracy of food intake recording was determined in a random subsample of 15 subjects by comparing water intake and water loss. 30 Water intake was measured using a food intake diary. Water intake was determined from reported food intake using a computer program (Becel Nutrition Program 1988) based on food tables. 29 Water loss was measured with the deuterium elimination method. 31 The evening before the start of the recording week, the subjects drank a weighed amount of deuterium solution ( 2 H 2 O) after collecting a baseline urine sample. Water loss was calculated from 2 H elimination in urine samples, collected on day 1 (in the morning and in the evening), day 7 (in the evening) and day 8 (in the morning). 31, 32 Deuterium content in the urine samples was measured with an isotope ratio mass spectrometer (Micromass Optima, Manchester, UK). Under normal conditions, water balance is preserved and water intake matches water loss. When water intake, corrected for metabolic water, is less than water loss, underrecording is present. 30 The deuterium dilution method was validated with the doubly labelled water method, showing that the recording precision of water intake was representative for total food recording. 30, 33 To ensure that food recording in these 15 subjects was not in¯uenced by the fact that they were aware that water intake and water loss were measured, the other subjects also followed the same protocol, but using tap water.
Satiety
Perception of satiety (hunger, satiety, fullness, desire to eat, appetite, estimation of how much one could eat, and thirst) was scored on anchored 100 mm visual analog scales at day 4 during baseline and day 11 during each intervention period. Questionnaires were completed at 10 ®xed time points, respectively just before and after breakfast, in the morning between 10 00 h and 11 00 h, before and after lunch, before and after a four o'clock snack, before and after dinner and in the evening between 22 00 and 23 00 h. 27 To characterize the development of satiation during a meal, questions on hunger, satiety and pleasantness of taste were answered on 100 mm visual analogue scales every 2 min during dinner consumed on the same day.
Tolerance
Tolerance of the intervention diets was determined at the end of each diet period using a questionnaire on occurrence of gastrointestinal and other complaints and scored on a ®ve point scale (0 never, 1 rarely, 2 sometimes, 3 often, 4 very often).
Hedonic value and user-friendliness Hedonic value and user-friendliness of the treatments were determined using a questionnaire which the subjects were asked to complete at the end of the experiment. The hedonic value of the semisolid meal was scored on a 0 ± 5 scale (0 not tasty at all, 1 not tasty, 2 less tasty, 3 rather tasty, 4 tasty, 5 very tasty). User-friendliness of the diets was scored on a 0 ± 2 scale (0 not user-friendly at all, 1 rather user-friendly, 2 user-friendly) and subjects were asked to say which diet they would prefer to use in the future.
Statistical analysis
Data are presented as mean AE standard error (s.e.). Differences between baseline and the treatments as well as differences between the treatments were determined by analysis of variance for repeated measures (ANOVA) and Sheffe-F post-hoc test (Statview SE Graphics TM ). The measurements at baseline and at the end of the experiment were compared using paired t-tests. Pearson correlation coef®cients were calculated to determine the relationship between selected variables. Level of signi®cance was set at P`0.05.
Results
During the entire experiment BW decreased by 4.4 AE 0.7 kg and BMI by 1.4 kg m À2 (P`0.001) in the whole group. Waist and hip circumferences were reduced both by 4 cm (P`0.001). The WHR did not change during the experiment. Body fat percentage determined in 15 subjects decreased by 3.8% (P`0.01).
Blood pressure also decreased during the experiment (diastolic, À17 mmHg; systolic, À10 mmHg; P`0.001). No change was found in blood glucose concentration.
Scores on the Herman Polivy questionnaire (frequency of dieting) and scores for factor 2 (disinhibition) and 3 (hunger) of the TFEQ were similar for all treatments. For factor 1 (restrained eating) signi®cantly increased scores were found during each of the intervention periods compared to baseline (P`0.01).
BW loss during 2 weeks treatment, irrespective of the order of treatment, was 2.1 AE 0.3, 1.6 AE 0.2 and 1.7 AE 0.3 kg during SSM , SSM and SM, respectively, with no signi®cant differences between treatments. During the ®rst intervention period BW loss was greater than during the second and third intervention periods (2.6 AE 0.2, 1.7 AE 0.2 and 1.1 AE 0.2 kg, respectively; P`0.001). SSM and SSM treatments resulted in an acute effect on BW. In SSM and SSM, BW loss was greater during the ®rst compared to the third intervention period (SSM , P`0.01; SSM, P`0.05). Treatment SM showed no difference in BW loss with respect to the different sequences. The SM ± SSM ± SSM intervention sequence was more effective in reducing BW than SSM ± SSM ± SM (P`0.05). From the start to the end of À1 , this would result in a total expected body weight loss of 5.9 kg during the three treatments combined. This is in line with the body weight loss found in this study (5.4 kg). Reduced energy intake resulted from reduction in fat, carbohydrate and alcohol intake ( Figure 2 ).
The following results on food intake are derived from the records in the food intake diaries. Fat, carbohydrate and alcohol intake was similar between the intervention periods. Dietary ®ber intake was reduced in the SSM treatment (P`0.001). Energy intake from the low-energy meals was higher during SSM and SSM compared to SM (2.5 AE 0.1, 2.5 AE 0.1 and 2.1 AE 0.1 MJ, respectively; P`0.001). Energy intake from the free dinner was 3.4 AE 0.2, 3.3 AE 0.2 and 3.1 AE 0.2 MJ during SSM , SSM and SM, respectively (NS). Energy intake from the snacks was lower in the SSM treatment (0.8 AE 0.2 MJ) compared to SM (1.6 AE 0.3 MJ; P`0.01) and was 1.0 AE 0.2 MJ during SSM. Food intake during each intervention was decreased during breakfast, in the morning, during lunch, and in the evening compared to baseline (P`0.001), but was similar during dinner (P 0.61, Figure 3) .
Energy intake during the dinner was similar for all situations (baseline, 3.1 AE 0.2 MJ; SSM , 3.4 AE 0.3 MJ; SSM, 4.0 AE 0.5 MJ; SM, 3.1 AE 0.3 MJ). The rate of change in satiety over the meal was smaller during SM compared to baseline (P`0.05). The rate of change in hunger and pleasantness of taste was similar for all situations ( Table 3) .
As they were instructed, the subjects consumed more meals and fewer snacks during the intervention periods compared to baseline (P`0.001). When considering the total number of meals plus snacks (eating moments), subjects ate more frequently during baseline compared to the ) as recorded using a food intake diary.
Guar gum and appetite EMR Kovacs et al intervention (P`0.001). In treatment SM, the subjects consumed fewer meals compared to SSM and SSM (P`0.001), but in total they had the same number of eating moments as in the treatments SSM and SSM because they compensated with snacks. The number of reported meals, snacks and eating moments during baseline, but not during the intervention, was positively correlated with BMI at baseline (r 0.39, r 0.47 and r 0.51, respectively; P`0.05).
Compliance to the dietary instructions during treatment SM was less good compared to SSM and SSM (P`0.001), but compliance was not related to body weight changes (SSM , r 0.32; SSM, r 0.33; SM, r 0.22; P b 0.05).
The ratings on the questions throughout the day, expressed as area under the curve (AUC), corrected for the subject's minimum score, are shown in Table 2 . The AUC of hunger was higher during treatments SSM and SM compared to baseline, but not during treatment SSM . Appetite, the estimation of how much one could eat and desire to eat (also expressed as AUC) during SSM treatment were higher compared to baseline; this was not the case during treatments SSM and SM. However, the differences from baseline in AUC of the appetite-related parameters with the SSM treatment were not different from the differences from baseline following SSM or SM. The AUC of fullness, satiety and thirst was not different between the four situations.
Diets were well tolerated. Intervention SSM resulted in a slightly higher incidence of nausea compared to SSM and SM (SSM , 0.3 AE 0.1; SSM, 0.0 AE 0.0; SM, 0.0 AE 0.0; P`0.05) and¯atulence compared to SM (SSM , 1.1 AE 0.2; SSM, Guar gum and appetite EMR Kovacs et al 0.7 AE 0.2; SM, 0.3 AE 0.1; P`0.05). However, values for complaints remained low. The hedonic value of the semisolid meal was 3.8 AE 0.1 on a 0 ± 5 scale. User-friendliness of the semisolid meal was 1.9 AE 0.1 on a 0 ± 2 scale, while user-friendliness of the solid meal was 1.2 AE 0.1 (P`0.001). SSM was rated as the most preferred treatment (by 18 out of 28 subjects) over SSM and SM (by 10 and six out of 28 subjects, respectively).
Discussion
All the three treatments were effective with respect to BW loss and EI reduction compared to baseline. Despite a reduced EI during the treatments compared to baseline, satiety, fullness and thirst had not changed. Nevertheless appetite-related parameters (hunger, appetite, desire to eat and estimation of how much one could eat) were increased with the semisolid meal alone and hunger with the solid meal. In contrast, addition of GG to the semisolid meal prevented an increase in appetite, hunger and desire to eat, although the differences between treatments were not statistically signi®cant. Also, with the SSM treatment snacking was signi®cantly lower than with the SM treatment, indicating a better sustained satiety between meals. Therefore addition of GG to the semisolid meal showed a rather modest effect on sustaining satiety or prevention of increased of hunger.
Modest weight loss of 5 ± 10%, which has been shown to contribute to reduction of mortality and morbidity in obese people, has been considered a realistic goal in dietary treatments. 34, 35 With supplementation of GG 10,11 or other dietary ®ber, 36 some positive results have been found in short-term studies. It has been proposed that soluble viscous ®ber, such as GG, may in¯uence satiety by decreasing the rate of gastric emptying and the small intestinal transit time.
12 ± 14 However, some recent studies also found opposite results. 37 ± 40 A decreased rate of gastric emptying andaor intestinal transit may delay glucose absorption. 15 It might be argued that the potential effect of GG on glucose absorption and on the insulinemic response may be less pronounced when a low-energy diet is consumed. However, it was even more interesting to assess whether such a mechanism would be effective with a low-energy diet. In this respect, in a separate study we found that addition of the same modi®ed GG to a low-energy semisolid meal resulted in a more moderate change in blood glucose and insulin after meal ingestion. 41 This may result in a prolonged feeling of satiety. 16 Evidence for long-term weight maintenance with dietary ®ber has been presented by a study by Hamilton and Anderson. 42 In some studies lasting less than a year, GG supplementation was shown to be bene®cial with respect to BW. 17, 18 However, in studies lasting more than a year, only Uusitupa et al 43 found a slight reduction in BW after GG supplementation, while other studies did not ®nd a bene®cial effect of GG supplementation on weight control. 44, 45 The EI reduction observed in different short-term studies may be an acute effect and may disappear when ®ber is supplemented for a longer period. This may be due to habituation to the ®ber. 44, 46 Several studies examined the effect of ®ber supplementation next to an energy-restricted diet on weight loss. Additional ®ber intake next to a lowenergy diet has been shown to be effective in several studies 20, 21 even during long-term treatment, 23 but not in all. 22 The prevention of increased hunger ratings when ®ber is supplemented may improve compliance to an energyrestricted diet 6, 20, 23 and subsequently increase the chances of successful weight loss or prevention of weight gain.
In the present study, no signi®cant difference in BW loss and EI was found between treatments. However, irrespective of the type of diet, the ®rst treatment was more effective on BW loss compared to the second and third treatments. This could be associated with the fact that, at the beginning of the experiment, the subjects were more motivated. A second possible reason would be that subjects had already lost some weight during the ®rst intervention and therefore further weight loss during the following treatments was more dif®cult to achieve. The SM ± SSM ± SSM sequence, that is the sequence that started with the solid meal, was more effective on BW loss compared to the SSM ± SSM ± SM sequence, that is the sequence that ended with the solid meal. Compliance to the treatment with the solid meal was less good compared to compliance with the treatments with the semisolid meals. Subjects had much more dif®culty in following the treatment with the solid meal as it was prescribed compared to the semisolid meal treatments. Furthermore, at the end of the experiment, the subjects indicated that the ready-to-eat semisolid meal was much more easy to use compared with the solid meals that they had to prepare themselves. Therefore, a low energy self-prepared solid meal will probably only be effective when used at the beginning of Guar gum and appetite EMR Kovacs et al a treatment. Thus, for longer-term treatments with a lowenergy meal, an alternating use of a ready-to-eat semisolid meal with a self-prepared solid meal might be more effective.
Daily mean recorded EI as well as fat, carbohydrate and alcohol intake were not different between treatments, but they were reduced compared to baseline. Dietary ®ber intake was reduced below the recommended level of 10 ga1000 kcal when the semisolid meal was used alone. This was not the case for the semisolid meal with GG and the solid meal. During dinner, when the subjects were allowed to eat what they liked, EI was similar for all four situations. This indicates that the low-energy diets were suf®cient, because the subjects did not compensate for the lower EI during the day by eating more during dinner. The number of meals increased, which was a treatment condition, but the number of snacks decreased during intervention. Using solid meals, the subjects consumed fewer meals than using semisolid meals. This indicated a poorer compliance to the prescribed regimen. However, eating more snacks compensated for the reduced meal frequency. A higher degree of underrecording was expected at baseline because, compared to the treatments when the subjects consumed three prescribed meals and only one meal was free, the subjects were free to eat whatever they liked. Because underrecording of food intake was similar in all situations, it was possible to use the data from the food intake diary in order to compare energy and macronutrient intake between treatments. Results from food intake diaries have been shown to be unreliable because of underrecording, especially in overweightaobese subjects. Underrecording in the present study (18 ± 24%) was higher compared to the results of Goris et al, 47 who found a 12% underrecording in obese men (BMI, 34.1 kg m
À2
) and no underrecording in highly motivated female dieticians with normal weight (BMI, 22.1 kg m À2 ). 30 Scores on cognitive restrained eating increased during the intervention periods, indicating that dieting had an effect on this aspect of eating behavior. 48 Because the subjects became more restrained, they were able to complete the treatment. However, the subjects were still classi®ed as unrestrained (score`9).
With respect to the effect of GG addition to a low-energy semisolid meal we conclude that the semisolid meal with or without GG and the solid meal were well tolerated and were effective on BW loss without affecting satiety negatively. However, in the case of the semisolid meal without GG and the solid meal, appetite-related parameters were increased, which was not the case for the semisolid meal with GG treatment, when these parameters remained at baseline level. Still, there was no signi®cant difference between the appetite parameters of SSM and SSM or SM. The semisolid meal with GG was found to be relatively more advantageous because it allowed a reduced EI together with the usual level of appetite scores and this treatment showed the higher preference, which observations contribute to possible compliance to such a diet on the longer term.
This type of treatment with three intervention periods of 2 weeks and washout periods in between has been shown to be relatively effective with respect to EI reduction and BW loss. During the treatments, EI was 3.3 ± 3.5 MJ lower compared to baseline, that is 142.8 MJ over 3Â14 days. For the whole group, EI reduction during treatments resulted in a BW loss of 4.4 kg for the entire intervention period. This BW loss was mainly attributed to a loss in body fat. Allison et al 49 observed that decreased mortality rate is likely to be dependent on the degree to which weight is lost as fat and not on the degree of weight loss per se. Assuming that an EI de®cit of 30 MJ results in a BW loss of 1 kg, 50 an energy de®cit of 132 MJ is needed to lose 4.4 kg. In other words, the observed energy de®cit over 3Â14 days (142.8 MJ) was in line with the expected energy intake reduction (132 MJ) and related to BW loss. Given the relatively short periods of effort during treatments and the washout periods, in which the subjects were not undergoing any restriction, this indicates that an intermittent treatment might be successful, although the success changes from an emphasis on body weight loss into prevention of body weight gain.
With respect to the type of treatment we conclude that the intermittent treatment used may be advantageous for a weight reduction or weight maintenance program. The main reason for this is prevention of habituation by means of the washout periods 44 and a more likely compliance because of the shorter periods of time.
